ConductScience.org, home

Paper34689986

Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: A meta-analysis of randomized controlled trials.

Masouros P and 2 others. Injury, 2022. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: A meta-analysis of randomized controlled trials. Papers, record 34689986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34689986

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: A meta-analysis of randomized controlled trials.
PubMed
Journal
Injury
PubMed
Year
2022
PubMed
Publication types
Journal Article, Meta-Analysis, Review
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
2.4
iCite
Revised in PubMed
2022-02-07
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Masouros PPanagiotis
2Antoniou GGeorgia
3Nikolaou VSVasileios S

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifibrinolytic AgentsMajor topic
Hip FracturesMajor topic
Tranexamic AcidMajor topic
Aged
Blood Loss, Surgical
Humans
Randomized Controlled Trials as Topic

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07432737One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip FracturesResults

Source ClinicalTrials.gov

Download CSV of trials

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42795921Efficacy of Tranexamic Acid in a Large Population with Proximal Femur Fractures-A Matched Pair Study of 7394 Patients from the Registry for Geriatric Trauma (ATR-DGU).J Clin Med2026https://conductscience.org/library/papers/42795921PubMed
42445619Perioperative Anemia and Transfusion Management in Older Adults with Osteoporotic Hip Fractures: A Narrative Review of Current Evidence and Emerging Strategies.Clin Interv Aging2026https://conductscience.org/library/papers/42445619PubMed
41900860Tranexamic Acid for Reduction of Blood Loss in Patients with Extracapsular Proximal Femur Fractures: Systematic Review and Meta-Analysis of Randomized Clinical Trials.Pharmaceutics2026https://conductscience.org/library/papers/41900860PubMed
40192873Efficacy and safety of Tranexamic acid use on postoperative blood transfusion in hip fracture patients- a systematic review and meta-analysis.Eur J Trauma Emerg Surg2025https://conductscience.org/library/papers/40192873PubMed
39912079Efficacy and Safety of Topical Tranexamic Acid in Elderly Hip Fractures Undergoing Surgical Treatment: Meta-Analysis of Randomized Controlled Trials.Clin Orthop Surg2025https://conductscience.org/library/papers/39912079PubMed
39247301Bibliometric and visualized analysis on hip fracture surgery and venous thromboembolism.Heliyon2024https://conductscience.org/library/papers/39247301PubMed
38831387A systematic review and meta-analysis of systematic and topical tranexamic acid administration in aesthetic plastic surgery.Perioper Med (Lond)2024https://conductscience.org/library/papers/38831387PubMed
38213943Effectiveness of Tranexamic Acid in Trauma Patients: A Systematic Review.Cureus2024https://conductscience.org/library/papers/38213943PubMed
37501145Intravenous application of tranexamic acid in intramedullary nailing for the treatment of geriatric intertrochanteric fractures: a systematic review and meta-analysis.BMC Musculoskelet Disord2023https://conductscience.org/library/papers/37501145PubMed
37294864Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews.Cochrane Database Syst Rev2023https://conductscience.org/library/papers/37294864PubMed
37272509Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures.Cochrane Database Syst Rev2023https://conductscience.org/library/papers/37272509PubMed
36826487General Anesthesia Versus Regional Anesthesia in the Elderly Patients Undergoing Hip Fracture Surgeries: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.World J Surg2023https://conductscience.org/library/papers/36826487PubMed

Download CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
TRANEXAMIC ACIDCHEMBL877Results1https://conductscience.org/library/drugs/CHEMBL877

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34689986

GET https://conductscience.org/api/papers/v1/34689986/authors